Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Daiichi Sankyo Ltd ADR (DSNKY)

Daiichi Sankyo Ltd ADR (DSNKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 5.73
  • Price/Book 1.14
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.5000 +2.05%
on 11/18/24
34.0200 -14.51%
on 10/30/24
-3.6450 (-11.14%)
since 10/21/24
3-Month
28.5000 +2.05%
on 11/18/24
42.4800 -31.53%
on 08/29/24
-11.2450 (-27.88%)
since 08/21/24
52-Week
26.1600 +11.18%
on 11/24/23
42.4800 -31.53%
on 08/29/24
+2.1850 (+8.12%)
since 11/21/23

Most Recent Stories

More News
1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer...

AZN : 63.93 (+1.16%)
DSNKY : 29.0850 (+0.64%)
MS : 135.37 (+2.79%)
PFE : 25.14 (+0.80%)
Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks...

PFE : 25.14 (+0.80%)
ABBV : 171.83 (+2.43%)
JNJ : 155.64 (+1.65%)
RHHBY : 35.3700 (+0.68%)
GMAB : 20.56 (+0.54%)
AZN : 63.93 (+1.16%)
DSNKY : 29.0850 (+0.64%)
MRK : 99.46 (+2.07%)
LLY : 748.65 (-0.63%)
NVO : 102.82 (-2.33%)
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 63.93 (+1.16%)
ONCY : 0.9809 (-1.76%)
ONC.TO : 1.39 (-0.71%)
DSNKY : 29.0850 (+0.64%)
GILD : 89.74 (+1.25%)
ARAY : 1.8600 (+1.64%)
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 63.93 (+1.16%)
ONCY : 0.9809 (-1.76%)
ONC.TO : 1.39 (-0.71%)
DSNKY : 29.0850 (+0.64%)
GILD : 89.74 (+1.25%)
ARAY : 1.8600 (+1.64%)
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?

In due time, its new partnership with Daiichi Sankyo could be massive.

MRK : 99.46 (+2.07%)
DSNKY : 29.0850 (+0.64%)
Is Gilead Sciences a Good Stock to Buy Now?

Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward.

PFE : 25.14 (+0.80%)
DSNKY : 29.0850 (+0.64%)
GILD : 89.74 (+1.25%)
AZN : 63.93 (+1.16%)

Business Summary

Daiichi Sankyo Co Ltd was founded on September 28, 2005. The Company is engaged in the research, development, manufacture, sale and marketing of pharmaceutical products. Its principal products include Olmesartan, an anti-hypertensive agent; Prasugrel, an antiplatelet agent; Memary and Donepezil for the...

See More

Key Turning Points

3rd Resistance Point 29.2533
2nd Resistance Point 29.1267
1st Resistance Point 29.0133
Last Price 29.0850
1st Support Level 28.7733
2nd Support Level 28.6467
3rd Support Level 28.5333

See More

52-Week High 42.4800
Fibonacci 61.8% 36.2458
Fibonacci 50% 34.3200
Fibonacci 38.2% 32.3942
Last Price 29.0850
52-Week Low 26.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar